An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab

NCT00930553 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1314

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting

Interventions

BIOLOGICAL: alemtuzumab

Sponsor

Genzyme, a Sanofi Company

Collaborators

[object Object]